Back to top
more

Novo Integrated Sciences (NVOS)

(Delayed Data from NSDQ)

$0.89 USD

0.89
3,220,032

-0.13 (-12.40%)

Updated Jun 14, 2024 04:00 PM ET

After-Market: $0.90 +0.01 (0.73%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Novo Integrated Sciences, Inc falls in the month of August.

All items in Millions except Per Share data.

8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019
Assets          
Cash & Equivalents 0 2 8 2 2
Receivables 3 2 2 2 2
Notes Receivable 0 0 0 0 0
Inventories 1 1 0 0 0
Other Current Assets 0 1 0 0 0
Total Current Assets 4 6 11 4 4
Net Property & Equipment 5 6 6 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 1 0 1
Deferred Charges 0 0 0 0 0
Intangibles 24 27 42 27 23
Deposits & Other Assets 0 0 0 0 1
Total Assets 36 41 62 35 32
Liabilities & Shareholders Equity 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019
Notes Payable 1 9 0 0 0
Accounts Payable 4 2 1 1 1
Current Portion Long-Term Debt 1 0 4 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 2 2 2 1 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 1 0 1 1
Total Current Liabilities 8 14 8 3 3
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1 1 2 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 1 6 1 1
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 11 19 18 6 7
Shareholders Equity 8/31/2023 8/31/2022 8/31/2021 8/31/2020 8/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 91 66 55 45 36
Retained Earnings -67 -54 -21 -17 -12
Other Equity 1 10 10 1 1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 25 22 44 30 26
Total Liabilities & Shareholder's Equity 36 41 62 35 32
Total Common Equity 25 22 44 30 26
Shares Outstanding 14.90 3.10 2.60 2.30 NA
Book Value Per Share 1.64 7.11 16.85 12.86 0.00

Fiscal Year End for Novo Integrated Sciences, Inc falls in the month of August.

All items in Millions except Per Share data.

5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Assets          
Cash & Equivalents -99,999 1 2 0 0
Receivables NA 3 4 3 2
Notes Receivable NA 0 0 0 0
Inventories NA 1 1 1 1
Other Current Assets NA 0 0 0 0
Total Current Assets NA 5 7 4 4
Net Property & Equipment NA 5 5 5 5
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 23 23 24 24
Deposits & Other Assets NA 0 0 0 0
Total Assets NA 35 37 36 36
Liabilities & Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Notes Payable NA 2 1 1 1
Accounts Payable NA 2 3 4 2
Current Portion Long-Term Debt NA 1 1 1 1
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 2 2 2 2
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 3 3 1 0
Total Current Liabilities NA 10 11 8 6
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1 1 1 1
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 0 0 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 13 14 11 9
Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 96 95 91 89
Retained Earnings NA -74 -72 -67 -64
Other Equity NA 0 -1 1 1
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 22 23 25 26
Total Liabilities & Shareholder's Equity NA 35 37 36 36
Total Common Equity 0 22 23 25 26
Shares Outstanding 19.00 17.70 17.20 14.90 14.40
Book Value Per Share 0.00 1.24 1.35 1.64 1.83